| 61.57 Data as of May 17 |  -0.13 / -0.21%Today’s Change | 12.87 Today|||52-Week Range 63.72 | +142.60% Year-to-Date |
| Aegerion Stock Falls On Unusually High Volume (AEGR) May 17 / TheStreet.com | 4 Stocks Improving Performance Of The Health Care Sector May 16 / TheStreet.com |
| Previous close | 61.70 |
| Today’s open | 61.73 |
| Day’s range | 58.83 - 62.69 |
| Volume | 1,792,712 |
| Average volume (3 months) | 625,898 |
| Market cap | $1.8B |
| Dividend yield | -- |
| Earnings growth (last year) | -30.05% |
| Earnings growth (this year) | +14.53% |
| Earnings growth (next 5 years) | +301.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 25.93 |
| Today’s change | Today’s % change | |
|---|---|---|
| IMGNImmunogen Inc | +0.21 | +1.31% |
| GEVASynageva Biopharma C... | +0.04 | +0.10% |
| HALOHalozyme Therapeutic... | -0.02 | -0.25% |
| ITMNInterMune Inc | -0.31 | -3.01% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$62.3M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman David I. Scheer |
Chief Executive Officer & Director Marc D. Beer |
Corporate headquarters Cambridge, Massachusetts |
.
